Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05977751 · ClinicalTrials.gov registry record · NA
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
A NA study of Contraception, sponsored by Femasys.
- Recruiting
- Registry status
- NA
- Development phase
- 573
- Enrollment target
- 8
- Study locations
NCT05977751 is a NA study of Contraception that is actively recruiting participants, run by Femasys. The registered enrollment target is 573 participants, above the 447-participant average among 72 other Contraception trials with a reported enrollment target (28% higher). The trial reports 8 study locations across 7 states.
The verdict
NCT05977751, a NA study of Contraception, is actively recruiting participants, sponsored by Femasys.
- RECRUITING
- Registry status
- NA
- Development phase
- 573 participants
- Enrollment target
- 8
- Study locations
Study Summary
Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.
Conditions Studied
Interventions
- DEVICE FemBloc
Study Locations (8)
California
- Stanford University - Palo Alto
- University of California Davis - Sacramento
Arizona
- New Horizons Clinical Trials - Chandler
Georgia
- Midtown OB GYN North - Columbus
Idaho
- Rosemark WomenCare Specialists - Idaho Falls
New York
- Maimonides Medical Center - Brooklyn
Ohio
- Seven Hills Women's Health Centers - Cincinnati
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 573 participants |
| Start Date | 2023-10-31 |
| Est. Completion | 2031-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05977751
The ClinicalTrials.gov registry entry for NCT05977751 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 573 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 447-participant average among 72 other Contraception trials with a reported enrollment target (28% higher). The listed sponsor is Femasys, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which FemBloc is the first listed.
NCT05977751 reports 8 study locations spanning 7 distinct geographic areas - top geographies include California, Arizona, Georgia.
Frequently Asked Questions
What is clinical trial NCT05977751 about?
NCT05977751 is a clinical study titled "Prospective Multi-Center Trial for FemBloc Permanent Birth Control". Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.
What is the current status of trial NCT05977751?
This trial is currently recruiting. It is a NA study. The enrollment target is 573 participants. The study started on 2023-10-31. Estimated completion is 2031-06.
What conditions does trial NCT05977751 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT05977751?
The interventions under investigation include: FemBloc (DEVICE).
Who is sponsoring clinical trial NCT05977751?
This trial is sponsored by Femasys, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05977751 being conducted?
This trial has 8 study locations across Arizona, California, Georgia, Idaho, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
-
Patient-centered Information on Permanent Contraception
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.